Product Name :
Pictilisib (GDC-0941)
CAS No.:
957054-30-7
Purity :
> 98%
Shipping:
Shipped on dry ice.
Storage :
Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month
SMILES:
C[S](=O)(=O)N1CCN(CC1)CC2=CC3=NC(=NC(=C3S2)N4CCOCC4)C5=CC=CC6=C5C=N[NH]6
Product Description :
Pictilisib (GDC-0941) is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM in cell-free assays, with modest selectivity against p110β (11-fold) and p110γ (25-fold). Phase 2.
Formula:
C23H27N7O3S2
Molecular Weight :
513.{{Atrasentan} MedChemExpress|{Atrasentan} Endothelin Receptor|{Atrasentan} Technical Information|{Atrasentan} In Vivo|{Atrasentan} supplier|{Atrasentan} Epigenetics} 64
Synonyms:
RG7321
Additional Information:
|CAS No.{{E 2012} web|{E 2012} Stem Cell/Wnt|{E 2012} Biological Activity|{E 2012} Data Sheet|{E 2012} custom synthesis|{E 2012} Epigenetics} 957054-30-7 ; |Synonyms RG7321 ; |Formula C23H27N7O3S2 ; |Molecular Weight 513.PMID:24202965 64 ; |SMILES C[S](=O)(=O)N1CCN(CC1)CC2=CC3=NC(=NC(=C3S2)N4CCOCC4)C5=CC=CC6=C5C=N[NH]6 ; |Target PI3Kα/δ ; |Product Description Pictilisib (GDC-0941) is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM in cell-free assays, with modest selectivity against p110β (11-fold) and p110γ (25-fold). Phase 2. ; |Purity > 98% ; |Shipping Shipped on dry ice. ; |Storage Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month ; |Solubility Overview Soluble in DMSO